Immunological response induced by abagovomab as a maintenance therapy in patients with epithelial ovarian cancer: relationship with survival-a substudy of the MIMOSA trial.
Cancer Immunol Immunother
; 63(10): 1037-45, 2014 Oct.
Article
in En
| MEDLINE
| ID: mdl-24952307
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
T-Lymphocytes, Cytotoxic
/
Neoplasms, Glandular and Epithelial
/
CA-125 Antigen
/
Membrane Proteins
/
Antibodies, Monoclonal
Type of study:
Clinical_trials
Limits:
Female
/
Humans
Language:
En
Journal:
Cancer Immunol Immunother
Journal subject:
ALERGIA E IMUNOLOGIA
/
NEOPLASIAS
/
TERAPEUTICA
Year:
2014
Document type:
Article
Affiliation country:
Italy
Country of publication:
Germany